Direct-to-the-Public Advertisement of Prescription Drugs
Cohen, Eric P.
New England Journal of Medicine. 1988 Feb 11; 318(6): 373-375.
Cohen, a physician, speaks out against direct-to-the-public advertising of prescription drugs by drug companies. He notes that Food and Drug Administration rules do not specifically forbid direct advertising of pharmaceuticals, although the agency's position is that such advertising is "not in the public interest." Cohen believes that "we are very close to widespread direct-to-the-public advertising of prescription medications," and examines the issues of regulation, cost, competition, public health, and patient well-being that are involved. He concludes that the use of prescription drugs would be "warped by misleading commercials and hucksterism," and calls upon physicians to inform regulators, lawmakers, and the drug industry of their opposition to direct advertising. (KIE abstract)
Showing items related by title, author, creator and subject.